Thank you, Russell and good morning everyone. This quarter, we once again had strong organic sales growth. We reduced the SG&A expense as a percent of sales and we grew our bottom line nicely. Each of our two divisions performed well. IDS grew segment profit by 5.5%, while WPS grew segment profit by 178% this quarter. And we took advantage of recent market pullbacks by repurchasing another 280,000 shares. Putting it altogether, we reported first quarter GAAP EPS of $0.79 compared to $0.67 in the first quarter of last year. And non-GAAP EPS which is calculated as our GAAP EPS less the after-tax impact of amortization expense was $0.84 this quarter compared to $0.72 in Q1 of last year. So the key financial takeaways this quarter are strong organic sales growth, nicely improved EPS, solid performance in each of our two divisions, and a continued commitment to returning funds to our shareholders. All of which helped us overcome the substantial appreciation of the U.S. dollar and deliver another very strong quarter. Let’s move to Slide #4 for our quarterly sales trends. Organic sales grew in each of our two segments, but with the stronger U.S. dollar, foreign currency translation reduced total company sales by 6.6%, thus bringing total sales growth to 0.3%. The impact of foreign currency reduced the IDS sales by 5.5% and reduced WPS sales by 10.3%. The reason for the outsized foreign currency impact on WPS is because approximately half of WPS sales are in Western Europe and another 20% of WPS sales are in Australia. Even with this significant foreign currency challenge, our WPS business still performed extremely well this quarter. On Slide #5, you will see our gross profit margin trending. Our gross profit margin decreased 10 basis points to 48.1% compared to 48.2% in the first quarter of last year. Looking at gross profit margin on a year-over-year basis, we were able to offset nearly all of our input cost increases. However, sequentially input cost increases are still running above our price increases, which was one of the drivers of a reduced sequential gross profit margin. Even though conditions are improving, we continue to experience scarce labor in certain geographies. And we are still seeing inflationary pressures continue across many different cost categories, from energy costs to raw material costs and everything in between. Although markets seem to be getting a bit better with respect to product availability and people availability, we haven’t seen it translate into reduced inflation quite yet. And even though price increases are partially offsetting inflation, we are still experiencing some lags between input cost increases and price increases. As such, we would expect to continue to see a bit of choppiness in our gross profit margins over the next several quarters. This quarter, we realized approximately 5.6% sales growth from pricing. On Slide #6, you’ll find our SG&A expense trending. SG&A was $89.9 million this quarter compared to $96.7 million in the first quarter of last year. As a percent of sales, SG&A was 27.9% this quarter compared to 30.1% in the first quarter of last year. If you exclude amortization expense, then SG&A would have declined from 28.9% of sales in Q1 of last year to 26.8% of sales this quarter. In addition to our continual focus on becoming a more efficient organization, SG&A expense also benefited from reduced incentive based compensation expense, reduced healthcare costs, and a reduction in SG&A expense due to foreign currency translation. Slide #7 is the trending of our investments in research and development. This quarter, we invested $13.9 million in R&D, which equates to about 4.3% of sales. A steady stream of new product launches is critical to our growth strategy. Accordingly, we remain committed to new product development as we see opportunities across our businesses, including our newest lines of printers and the building out of a comprehensive industrial track-and-trace platform that encompasses our printers, high-quality materials, RFID scanners and barcode scanners. This quarter’s R&D spend was a bit less than we would expect in future quarters due to the timing of project spend and a reduction in incentive-based compensation. On Slide #8, you can see that pre-tax earnings increased to 12.6% on a GAAP basis. If you exclude amortization expense from both the current year and the prior year, then our non-GAAP pre-tax earnings would have increased by 11.3%, increasing from $48.5 million in Q1 of last year to $54 million this quarter. Slide #9 shows the trending of earnings and EPS on an after-tax basis. When you look at these charts, you can see that the general trend of up into the right as we have now had two consecutive years of record EPS and we are off to a good start once again this year. On Slide #10, you will find a summary of our cash generation. Operating cash flow increased this quarter despite accelerating the timing of our annual incentive-based compensation payments into the first quarter and increasing inventories to both support our increased sales volumes as well as to ensure that we can support our customers in the event of further supply chain challenges. As it relates to incentive-based comp, last year, we made our annual payments in the second quarter, whereas this year, we made these payments which were approximately $24 million in the first quarter. Accordingly, we expect our second quarter cash generation to be quite a bit stronger than what we experienced last year. Now if you will turn to Slide #11, you can see the impact that Brady’s historical cash generation has had on our balance sheet. Even after stepping up our share buybacks and building up inventories over the last year or so, on October 31, we were still in a net cash position of $15.5 million. Our approach to capital allocation is to first and foremost use our cash to fully fund organic sales and efficiency opportunities. This includes investing in new product development, sales generating resources, capability enhancing capital expenditures, and automation focused CapEx. Despite the economic uncertainty, we will continue to deploy capital to drive productivity and sales growth, especially in our businesses, where we expect enhanced growth from secular tailwinds. And second, we focus on consistently increasing our dividends. We have increased our dividends every single year since going public. After fully funding organic investments and dividends, we then deploy our capital in a disciplined manner for either acquisitions where we have clear synergistic opportunities or for buybacks in a highly opportunistic manner when we see a disconnect between Brady’s intrinsic value and Brady’s trading price. Our enviable balance sheet positions us well to execute additional value enhancing activities, including investing in R&D, completing acquisitions, and returning funds to our shareholders. As we look to the future, we are confident that the actions we have taken set us up for success. But of course, we can’t control the macro economy and we can’t control foreign currency rates. Based on exchange rates as of October 31, the strengthening of the U.S. dollar is expected to reduce our sales by approximately 5% for the full fiscal year ending July 31, 2023. To put this in perspective, when we provided our initial fiscal ‘23 guidance, just a few months ago, we expected a full year foreign currency headwind of approximately 3.5% and it’s now increased to a headwind of 5%. As it relates to EPS, the impact of foreign currency is expected to reduce our fiscal ‘23 EPS by approximately $0.20 per share when compared to last year’s foreign currency exchange rates. This brings us to our fiscal ‘23 guidance which is articulated on Slide 12 of the deck. Even with these increased foreign currency headwinds, we are maintaining our full year fiscal 2023 previously established EPS guidance range of $3.30 to $3.60 per share on a non-GAAP basis and $3.13 to $3.43 per share on a GAAP basis. Our outlook is based on October 31 exchange rates and we expect continued economic expansion. While we acknowledge that market conditions remain uncertain and we are certainly hearing and feeling increased concern over the future, we have not yet seen a meaningful slowdown in our order patterns and we continue to have positive momentum. As such, we expect that organic sales growth will remain consistent with our initial guidance range of mid to high single-digit percentage growth for the year ending July 31 2023. The other elements of our guidance range are also unchanged and include an income tax rate of approximately 20%, depreciation and amortization expense of approximately $32 million to $34 million, and capital expenditures of approximately $32 million. As per capital allocation, we don’t foresee any major changes in our strategy. We will keep investing in our organic business. Yesterday, we announced our quarterly dividend and we will be opportunistic with buybacks while looking for acquisitions where the price is right and the strategic fit is clear. We have a strong balance sheet and we will use it as a tool to drive long-term shareholder value. Potential risks to this guidance, among others, includes further strengthening of the U.S. dollar, inflationary pressures that we can’t offset in a timely enough manner through price increases or an overall slowdown in economic activity. I will now turn the call back over to Russell to cover our divisional results and to provide some closing thoughts before Q&A. Russell?